Teyi Pharmaceutical Group Co Ltd (002728) — Financial Flexibility Index
Teyi Pharmaceutical Group Co Ltd (002728) has a Financial Flexibility Index of 0.16x as of December 2025. Free cash flow of CN¥76.63 Million (operating CF CN¥52.94 Million minus capex CN¥23.69 Million) represents 0% of total liabilities (CN¥472.69 Million). Also explore how fast is Teyi Pharmaceutical Group Co Ltd growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Teyi Pharmaceutical Group Co Ltd Financial Flexibility Index (2009–2025)
Historical Financial Flexibility Index trend for Teyi Pharmaceutical Group Co Ltd across 17 annual periods. Check 002728 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Teyi Pharmaceutical Group Co Ltd (2009–2025)
Year-by-year free cash flow to debt coverage for Teyi Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see how much is Teyi Pharmaceutical Group Co Ltd worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥324.43 Million | CN¥244.88 Million | CN¥472.69 Million | ▲ +379.6% |
| 2024 | 0.14x | CN¥91.01 Million | CN¥-22.55 Million | CN¥635.94 Million | ▼ -74.8% |
| 2023 | 0.57x | CN¥284.60 Million | CN¥198.56 Million | CN¥501.95 Million | ▲ +40.2% |
| 2022 | 0.40x | CN¥461.92 Million | CN¥371.66 Million | CN¥1.14 Billion | ▼ -11.2% |
| 2021 | 0.46x | CN¥366.39 Million | CN¥256.81 Million | CN¥804.51 Million | ▲ +107.2% |
| 2020 | 0.22x | CN¥258.40 Million | CN¥168.99 Million | CN¥1.18 Billion | ▼ -31.2% |
| 2019 | 0.32x | CN¥352.44 Million | CN¥221.64 Million | CN¥1.10 Billion | ▼ -10.3% |
| 2018 | 0.36x | CN¥340.41 Million | CN¥187.97 Million | CN¥956.39 Million | ▲ +119.7% |
| 2017 | 0.16x | CN¥143.59 Million | CN¥102.96 Million | CN¥886.14 Million | ▼ -57.3% |
| 2016 | 0.38x | CN¥272.15 Million | CN¥101.30 Million | CN¥716.61 Million | ▲ +77.2% |
| 2015 | 0.21x | CN¥170.11 Million | CN¥68.87 Million | CN¥793.78 Million | ▼ -77.1% |
| 2014 | 0.94x | CN¥84.33 Million | CN¥57.35 Million | CN¥89.96 Million | ▼ -19.4% |
| 2013 | 1.16x | CN¥120.28 Million | CN¥74.23 Million | CN¥103.40 Million | ▼ -12.5% |
| 2012 | 1.33x | CN¥136.70 Million | CN¥104.50 Million | CN¥102.88 Million | ▼ -1.1% |
| 2011 | 1.34x | CN¥77.53 Million | CN¥69.81 Million | CN¥57.71 Million | ▲ +119.2% |
| 2010 | 0.61x | CN¥50.21 Million | CN¥46.92 Million | CN¥81.92 Million | ▲ +101.2% |
| 2009 | 0.30x | CN¥26.34 Million | CN¥22.32 Million | CN¥86.47 Million | — |